Clinical Trial Update: A Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Alone or in Combination With a Sulphonylurea [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy, safety, and tolerability of canagliflozin in adults with type 2 diabetes mellitus inadequately controlled on metformin (w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Invokana (canagliflozin) (canagliflozin)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2014-01-09